G61.8
Conditions
Interventions
Group 1: Patients with chronic immune neuropathies under IVIg therapy:
1st examination, under IVIg therapy at previous dose: MRC Sum Score, INCAT Overall Disability Score, Rasch-built Overall Disabil
Sponsors
Neurologische KlinikUniversitätsklinikum Aachen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) confirmed CIDP or MMN according to the latest reviewed EFNS/PNS diagnostic criteria 2) age of at least 18 years, there is no upper age limitation 3) regular therapy with IVIg at the neurological clinic of the University Hospital Aachen. 4) planned extension of the dosing interval or a planned dose reduction of IVIg therapy (clinically stable condition under established therapy regimen for =2 therapy cycles (median 4 weeks) prior to inclusion). 5) written informed consent for the storage and analysis of anonymised, patient-related clinical data
Exclusion criteria
Exclusion criteria: 1) lack of informed consent and non-fulfilment of inclusion criteria. 2) higher degree of functionally relevant systemic or hand-related previous disease/damage that would be associated with a relevant functional limitation of hand function beyond CIDP or MMN 3) other pre-existing and concomitant diseases that do not allow meaningful participation in the study (e.g. dementia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time (a total of at least 5 time points planned before and after therapy adjustment) | — |
Countries
Germany
Contacts
Public ContactPascal Achenbach
Neurologische KlinikUniversitätsklinikum Aachen
Outcome results
None listed